Gabapentin Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Gabapentin Market
1.1. Definition and Scope
1.1.1. Definition of Gabapentin
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Gabapentin Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Gabapentin Market By Dosage
1.2.3. Gabapentin Market By Type
1.2.4. Gabapentin Market By Application
1.2.5. Gabapentin Market By Distribution Channel
1.2.6. Gabapentin Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Source
2.2.2. Primary Source
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Gabapentin Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Gabapentin Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Price Trend of Key Raw Material
3.8.1. Raw Material Suppliers
3.8.2. Proportion of Manufacturing Cost Structure
3.8.2.1. Raw Material
3.8.2.2. Labor Cost
3.8.2.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Gabapentin Market By Dosage
5.1. Introduction
5.2. Gabapentin Revenue By Dosage
5.2.1. Gabapentin Revenue (USD Billion) and Forecast, By Dosage, 2020-2032
5.2.2. Tablet
5.2.2.1. Tablet Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Oral Solution
5.2.3.1. Oral Solution Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Capsule
5.2.4.1. Capsule Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Gabapentin Market By Type
6.1. Introduction
6.2. Gabapentin Revenue By Type
6.2.1. Gabapentin Revenue (USD Billion) and Forecast, By Type, 2020-2032
6.2.2. Branded
6.2.2.1. Branded Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Generic
6.2.3.1. Generic Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Gabapentin Market By Application
7.1. Introduction
7.2. Gabapentin Revenue By Application
7.2.1. Gabapentin Revenue (USD Billion) and Forecast, By Application, 2020-2032
7.2.2. Epilepsy
7.2.2.1. Epilepsy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Restless Legs Syndrome
7.2.3.1. Restless Legs Syndrome Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Neuropathic Pain
7.2.4.1. Neuropathic Pain Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.5. Others
7.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. Gabapentin Market By Distribution Channel
8.1. Introduction
8.2. Gabapentin Revenue By Distribution Channel
8.2.1. Gabapentin Revenue (USD Billion) and Forecast, By Distribution Channel, 2020-2032
8.2.2. Hospital Pharmacy
8.2.2.1. Hospital Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. Online Pharmacy
8.2.3.1. Online Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.4. Retail Pharmacy
8.2.4.1. Retail Pharmacy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Gabapentin Market By Country
9.1. North America Gabapentin Market Overview
9.2. U.S.
9.2.1. U.S. Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032
9.2.2. U.S. Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032
9.2.3. U.S. Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032
9.2.4. U.S. Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.3. Canada
9.3.1. Canada Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032
9.3.2. Canada Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032
9.3.3. Canada Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032
9.3.4. Canada Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Gabapentin Market By Country
10.1. Europe Gabapentin Market Overview
10.2. U.K.
10.2.1. U.K. Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032
10.2.2. U.K. Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032
10.2.3. U.K. Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032
10.2.4. U.K. Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.3. Germany
10.3.1. Germany Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032
10.3.2. Germany Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032
10.3.3. Germany Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032
10.3.4. Germany Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.4. France
10.4.1. France Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032
10.4.2. France Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032
10.4.3. France Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032
10.4.4. France Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.5. Spain
10.5.1. Spain Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032
10.5.2. Spain Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032
10.5.3. Spain Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032
10.5.4. Spain Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032
10.6.2. Rest of Europe Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032
10.6.3. Rest of Europe Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032
10.6.4. Rest of Europe Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Gabapentin Market By Country
11.1. Asia Pacific Gabapentin Market Overview
11.2. China
11.2.1. China Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032
11.2.2. China Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032
11.2.3. China Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032
11.2.4. China Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.3. Japan
11.3.1. Japan Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032
11.3.2. Japan Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032
11.3.3. Japan Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032
11.3.4. Japan Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.4. India
11.4.1. India Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032
11.4.2. India Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032
11.4.3. India Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032
11.4.4. India Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.5. Australia
11.5.1. Australia Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032
11.5.2. Australia Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032
11.5.3. Australia Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032
11.5.4. Australia Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.6. South Korea
11.6.1. South Korea Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032
11.6.2. South Korea Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032
11.6.3. South Korea Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032
11.6.4. South Korea Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032
11.7.2. Rest of Asia-Pacific Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032
11.7.3. Rest of Asia-Pacific Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032
11.7.4. Rest of Asia-Pacific Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Gabapentin Market By Country
12.1. Latin America Gabapentin Market Overview
12.2. Brazil
12.2.1. Brazil Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032
12.2.2. Brazil Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032
12.2.3. Brazil Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032
12.2.4. Brazil Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
12.3. Mexico
12.3.1. Mexico Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032
12.3.2. Mexico Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032
12.3.3. Mexico Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032
12.3.4. Mexico Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032
12.4.2. Rest of Latin America Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032
12.4.3. Rest of Latin America Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032
12.4.4. Rest of Latin America Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Gabapentin Market By Country
13.1. Middle East & Africa Gabapentin Market Overview
13.2. GCC
13.2.1. GCC Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032
13.2.2. GCC Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032
13.2.3. GCC Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032
13.2.4. GCC Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
13.3. South Africa
13.3.1. South Africa Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032
13.3.2. South Africa Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032
13.3.3. South Africa Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032
13.3.4. South Africa Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Gabapentin Revenue (USD Billion) and Forecast By Dosage, 2020-2032
13.4.2. Rest of Middle East & Africa Gabapentin Revenue (USD Billion) and Forecast By Type, 2020-2032
13.4.3. Rest of Middle East & Africa Gabapentin Revenue (USD Billion) and Forecast By Application, 2020-2032
13.4.4. Rest of Middle East & Africa Gabapentin Revenue (USD Billion) and Forecast By Distribution Channel, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Gabapentin Market
14.1. Gabapentin Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking Of Key Players By Price, Presence, Market Share, And R&D Investment
14.2.2. New ProductLaunches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Gabapentin Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Pfizer Inc.
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2022
15.1.3.2. Pfizer Inc. 2022 Gabapentin Business Regional Distribution
15.1.4. Product/Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Mylan N.V.
15.3. Aurobindo Pharma Ltd.
15.4. Teva Pharmaceutical Industries Ltd.
15.5. Lupin Limited
15.6. Sun Pharmaceutical Industries Ltd.
15.7. Novartis AG
15.8. Cadila Healthcare Ltd. (Zydus Cadila)
15.9. Torrent Pharmaceuticals Ltd.
15.10. Dr. Reddy's Laboratories Ltd.
15.11. Sandoz International GmbH
15.12. Apotex Inc.
Frequently Asked Questions
How big is gabapentinin market?
The market size of gabapentin was USD 2.4 Billion in 2022.
What is the CAGR of the global gabapentin market from 2023 to 2032?
The CAGR of gabapentin is 5.7% during the analysis period of 2023 to 2032.
Which are the key players in the gabapentin market?
The key players operating in the global market are including Pfizer Inc., Mylan N.V., Aurobindo Pharma Ltd., Teva Pharmaceutical Industries Ltd., Lupin Limited, Sun Pharmaceutical Industries Ltd., Novartis AG, Cadila Healthcare Ltd. (Zydus Cadila), Torrent Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Sandoz International GmbH, and Apotex Inc.
Which region dominated the global gabapentin market share?
North America held the dominating position in gabapentin industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of gabapentin during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global gabapentin industry?
The current trends and dynamics in the Gabapentin industry include increasing prevalence of neuropathic pain disorders, off-label use for mood disorders and anxiety, and continuous research and development efforts.
Which type held the maximum share in 2022?
The generic type held the maximum share of the gabapentin industry.
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
